Results 111 to 120 of about 35,855 (199)

Evolving nutrition therapy in cystic fibrosis: Adapting to the CFTR modulator era

Nutrition in Clinical Practice, Volume 40, Issue 4, Page 816-828, August 2025.
Abstract Cystic fibrosis transmembrane regulator (CFTR)–directed therapies, such as modulators, have transformed the medical management of people with CF, resulting in better lung function, weight, and body mass index in recent years. With improved nutrition status in people on CFTR modulators, the emphasis on a high‐energy, high‐fat diet (the legacy ...
Kay Vavrina, Tara B. Griffin, Angel M. Jones, Terri Schindler, Trang N. Bui, Senthilkumar Sankararaman   +5 more
wiley   +1 more source

Colectomy and Neoplasia Outcomes of Patients With Ulcerative Colitis Receiving Golimumab: A Post‐Authorisation Safety Study Using the Spanish ENEIDA Registry

Pharmacoepidemiology and Drug Safety, Volume 34, Issue 8, August 2025.
ABSTRACT Purpose Golimumab (GLM), an anti‐tumour necrosis factor alpha (anti‐TNFα) agent, is indicated for moderate to severe ulcerative colitis (UC). This post‐authorisation safety study evaluated the risk of colectomy due to intractable disease and advanced colonic neoplasia (high‐grade dysplasia and/or colorectal cancer) under real‐world conditions ...
Eugeni Domènech, Joan Fortuny, David Martínez, Anita Tormos, Zhiping Huang, Deanna D. Hill, Cindy Weinstein, Suzan Esslinger, Alexis A. Krumme, Marijo Otero‐Lobato, Daniel Mines, Javier P. Gisbert, On Behalf of the ENEIDA Study Group of GETECCU, Beatriz Sicilia, David Monfort I Miquel, Xavier Calvet Calvo, Miguel Mínguez Pérez, Luis Fernández Salazar, Esther García Planella, Joaquín de Hinojosa de Val, Rufo H. Lorente Poyatos, Luis Bujanda, Mariana Fe Garcia Sepulcre, Ana Gutiérrez Casbas, Eugeni Domènech, Lucía Márquez Mosquera, Maria Dolores Martin Arranz, Javier P. Gisbert, Maria Esteve Comas, Antonio López San Roman, Guillermo Bastida Paz, Jose Manuel Benitez Cantero, Manuel Van Domselaar, Xavier Aldeguer, Fernando Bermejo, Jose Lazaro Perez Calle, Montserrat Rivero Tirado, Santiago Garcia López, Jesús Barrio Andrés, Guillermo Alcaín Martinez, Elena Ricart Goméz, Carla J. Gargallo Puyuelo, Miguel Ángel Montoro Huguet   +42 more
wiley   +1 more source

Biliary dilation using a screw-type device for endoscopic ultrasound-hepaticogastrostomy in a relapsed primary sclerosing cholangitis case post-liver transplantation. [PDF]

Endoscopy
Okuno M, Kataoka F, Araki H, Tomita E, Matsunami H, Moriwaki H, Shimizu M.   +6 more
europepmc   +1 more source

Sclerosing cholangitis: Liver transplantation [PDF]

, 1989
Marsh, JW, Starzl, TE
core  

Diabetes Mellitus in Patients With Autoimmune Hepatitis: Frequency, Risk Factors and Effect on Outcome

Alimentary Pharmacology &Therapeutics, Volume 62, Issue 3, Page 319-329, August 2025.
New‐onset DM occurred in 13% of patients with AIH, was related to older age, non‐Caucasian ethnicity, higher prednisolone dose, higher BMI at diagnosis and weight gain and was an independent predictor of all‐cause death/transplantation and of cirrhosis development, underlining the need to minimise steroid burden in AIH.
Sarah Flatley, Selena Dixon, Eleanor Pilsworth, Asha Dube, Barbara Hoeroldt, Laura Harrison, Dermot Gleeson   +6 more
wiley   +1 more source

Risk assessment of gallbladder cancer in patients with primary sclerosing cholangitis and gallbladder polyps: a systematic review. [PDF]

Langenbecks Arch Surg
Grikyte I, Ignatavicius P.
europepmc   +1 more source

The Deadly Masquerade: Unveiling the Fatal Facade of the Great Imitator. [PDF]

Cureus
Ellett TR, Pippas A, Rios H, Jabbar SB.
europepmc   +1 more source

Sketching T cell atlases in the single‐cell era: challenges and recommendations

Immunology &Cell Biology, Volume 103, Issue 7, Page 723-737, August 2025.
Recent advances in single‐cell technologies have enabled the creation of T cell atlases, providing detailed maps of adaptive immunity across tissues, development and disease states. These atlases help uncover T cell diversity, functional states and disease mechanisms, aiding in the identification of therapeutic targets.
Itana Bojović, António GG Sousa, Sini Junttila, Laura L Elo   +3 more
wiley   +1 more source

Phenotypic Differences and Clinical Outcomes of South Asian Children With IBD: A Singapore–Malaysia Study From the Asian PIBD Registry Network

Journal of Gastroenterology and Hepatology, Volume 40, Issue 8, Page 1933-1941, August 2025.
ABSTRACT Background and Aim Existing literature largely contrasts pediatric inflammatory bowel disease (PIBD) phenotypic differences and outcomes of South Asians (SAs) with Caucasians. No published comparative data exist between SAs and non‐SAs within Asia‐Pacific.
James Guoxian Huang, Kee Seang Chew, Veena Logarajah, Way Seah Lee, Marion Margaret Aw   +4 more
wiley   +1 more source

Oral vancomycin is associated with less therapy intensification in adults with symptomatic inflammatory bowel disease and underlying primary sclerosing cholangitis. [PDF]

Ann Gastroenterol
Kulkarni C, Talamantes S, Dimopoulos-Verma A, Fardeen T, Khan S, Cholankeril G, Triadafilopoulos G, Sinha SR.   +7 more
europepmc   +1 more source